Some patients experience significant body composition changes, losing fat while maintaining or even gaining muscle, that the scale does not capture
Market and Regulatory Pressure: Where the System Is Moving The rapid expansion of GLP-1 therapies has placed them at the center of market competition, regulatory scrutiny, and policy debate
Understanding how GLP-1 regulates inflammation will provide insights into the pleiotropic benefits of GLP-1 receptor (GLP-1R) agonism
For example, organizations like the American Diabetes Association suggest that GLP-1 therapies can be used early, even as first-line treatment in certain cases
Better lab values
Additionally, psychological factors including stress, sleep quality, and eating behaviours influence outcomes